According to the criteria we set for characterization of findings as true positive or false negative, the overall per-patient sensitivity of [18F]FDG-PET/CT was 44.1% (26/59) in detecting MTC lesions in patients with increased serum calcitonin levels and either negative or equivocal conventional imaging. This evidence concerns the gene CALCA and medullary thyroid gland carcinoma.